Home › NDC Lookup › RxCUI directory › RxCUI 1235151

Azilsartan medoxomil 40 MG / chlorthalidone 25 MG Oral Tablet — RxCUI 1235151

RxNorm drug concept · Semantic clinical drug
RxCUI 1235151 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1235151
Official nameAzilsartan medoxomil 40 MG / chlorthalidone 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)3,595 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Azilsartan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Azilsartan medoxomil — available as the generic Azilsartan Medoxomil or the brand Edarbi — is used to treat high blood pressure in adults. By lowering your blood pressure, it also...
  • No — food doesn't affect how much of the drug your body absorbs, so you can take it however is most convenient for you. The most important thing is to take it at roughly the same t...
  • Does it matter if I take it with food or on an empty stomach?
  • Most people do really well on azilsartan. The most commonly reported issue is diarrhea, and some people notice dizziness — especially when standing up quickly — nausea, fatigue, mu...
📖 Read our full Azilsartan guide →

🕸️ Concept Web — How Azilsartan medoxomil 40 MG / chlorthalidone 25 M... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Azilsartan medoxomil 40 MG / chlorthalidone 25 MG Oral Tablet RxCUI 1235151

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Azilsartan 1091643
    • Chlorthalidone 2409
    • Azilsartan / chlorthalidone 1235143
    • Azilsartan medoxomil 1091642
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Edarbyclor 1372759
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Azilsartan / chlorthalidone Oral Tablet 1235142
    • Azilsartan medoxomil / chlorthalidone Oral Tablet 2649217
    • Azilsartan / chlorthalidone Oral Product 1235140
    • Azilsartan / chlorthalidone Pill 1235141
    • Azilsartan medoxomil / chlorthalidone Oral Product 2662871
    • Azilsartan medoxomil / chlorthalidone Pill 2659556
    • Azilsartan / chlorthalidone Oral Tablet [Edarbyclor] 1235147
    • Azilsartan medoxomil / chlorthalidone Oral Tablet [Edarbyclor] 2658673
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Azilsartan medoxomil 40 MG SCDC · 1091644
  • Chlorthalidone 25 MG SCDC · 315655
  • Azilsartan / chlorthalidone Oral Tablet SCDF · 1235142
  • Azilsartan medoxomil / chlorthalidone Oral Tablet SCDFP · 2649217
  • Azilsartan / chlorthalidone Oral Product SCDG · 1235140
  • Azilsartan / chlorthalidone Pill SCDG · 1235141
  • Azilsartan medoxomil / chlorthalidone Oral Product SCDGP · 2662871
  • Azilsartan medoxomil / chlorthalidone Pill SCDGP · 2659556

Brand-Name Concepts

  • Azilsartan medoxomil 40 MG / chlorthalidone 25 MG Oral Tablet [Edarbyclor] SBD · 1235157
  • Azilsartan medoxomil 40 MG / chlorthalidone 25 MG [Edarbyclor] SBDC · 1235153
  • Azilsartan / chlorthalidone Oral Tablet [Edarbyclor] SBDF · 1235147
  • Azilsartan medoxomil / chlorthalidone Oral Tablet [Edarbyclor] SBDFP · 2658673
  • Edarbyclor Oral Product SBDG · 1235148
  • Edarbyclor Pill SBDG · 1235149
  • Edarbyclor BN · 1372759

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1235151 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
60631-0412-30 30 TABLET in 1 BOTTLE (60631-412-30) Edarbyclor Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) 2013-02-01
60631-0425-30 30 TABLET in 1 BOTTLE (60631-425-30) Edarbyclor Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) 2013-02-01
75929-0230-03 30 TABLET in 1 BOTTLE (75929-230-03) Edarbyclor Pharma Packaging Solutions, LLC dba Tjoapack LLC 2013-02-01
Observed labelers: Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) (2) · Pharma Packaging Solutions, LLC dba Tjoapack LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.